Table 2.

Demographic and clinical details of HLA-A2- CHB patients

	Patient ID	Gender	Age (years)	Genotype	Therapy	HBsAg (IU/mL)	Anti HBs (UI/mL)	HBeAg (IU/mL)	ALT (IU/L)	HBV-DNA (UI/mL)
CHB	CHB 36	M	63	D	Naive	996	–	–	58	76 222
	CHB 37	F	67	A	Naive	15 970	–	–	42	9856
	CHB 38	M	20	n.a	Naive	3761	–	–	24	246
	CHB 39	F	42	D	Naive	7921	–	–	42	121 774
	CHB 40	F	52	n.a	Naive	13 945	–	–	86	1 848 322
	CHB 41	M	43	D	Naive	5459	–	–	113	1 180 000
	CHB 42	M	48	D	Naive	17 589	–	–	50	3 880 200
	CHB 43	M	81	n.a	Naive	11 695	–	–	116	2 866 690
	CHB 44	M	37	D	Naive	182	–	–	27	11 995
	CHB 45	F	44	D	Naive	691	–	–	31	10 120
	CHB 46	M	37	D	Naive	65 626	–	–	26	169 601
	CHB 47	F	61	D	Naive	3865	–	–	142	234 140
	CHB 48	M	54	D	Naive	18 436	–	–	55	1 890 237
	CHB 49	M	50	C	Naive	2028	–	–	222	12 030 348
	CHB 50	M	50	D	Naive	11 557	–	–	24	12 102
	CHB 51	M	36	D	Naive	7458	–	–	25	47 946
	CHB 52	F	29	D	Naive	30 606	–	+	59	1,35E+08
	CHB 53	M	23	D	Naive	9329	–	–	26	5837
	CHB 54	M	59	D	Naive	55 988	–	+	72	3,49E+08
	CHB 55	F	71	D	Naive	231	–	–	25	280 155
	CHB 56	F	46	D	Naive	662	–	–	19	3140
	CHB 57	M	64	D	Naive	228	–	–	19	116 997
	CHB 58	M	29	n.a	Naive	1223	–	–	54	2050
	CHB 59	M	47	D	Naive	8181	–	–	212	150 300

CHB, chronic hepatitis B; HBV, hepatitis B virus; n.a, not available.